Rituximab as a first-line agent for the treatment of dermatomyositis.
Haroon
Muhammad
M
Department of Rheumatology, Waterford Regional Hospital, Waterford, Republic of Ireland. mharoon301@hotmail.com
Devlin
Joe
J